Caribou Biosciences, Inc.
CRBUBiotechnology
$0.45−9.07%As of Oct 29vs prior close
- Market cap
- $47.7M
- P/E (TTM)
- –
- From 52W high
- −81.69%
- EPS (LTM)
- -$1.08
- Revenue (LTM)
- $10M
- Net margin
- -1030.42%
- Dividend yield
- 0.00%
Nomior Score
24
Distressed LaggardSpeculativeBottom 10% of the scored universe
Growth—
Quality27
Value—
Momentum22
Resilience30
Growth
+11.56%revenue a year over 6 fiscal years
YE19 $5.8MLTM $10M
Connections
Revenue to profitQ2 YE26
The operating loss was 1690% of revenue, narrower by 94 pts on a year.
Who owns it
2funds, 1 tracked portfolio